‘I’m sober, Doctor, really’: Best biomarkers for underreported alcohol use — Current Psychiatry Online: When and how to use highly specific combinations to assess withdrawal risk
Biological Psychiatry - Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression: A preliminary report in six patients suggested that deep brain stimulation (DBS) of the subcallosal cingulate gyrus (SCG) may provide benefit in treatment-resistant depression (TRD). We now report the results of these and an additional 14 patients with extended follow-up.
Selecting Among Second-Step Antidepressant Medication Monotherapies: Predictive Value of Clinical, Demographic, or First-Step Treatment Features, August 2008, Rush et al. 65 (8): 870: Clinical, demographic, and treatment history were of little value in recommending 1 medication vs another as a second-step treatment for major depressive disorder. Participants most likely to remit in the second step had less Axis I psychiatric disorder comorbidity, less social disadvantage, and at least a response to citalopram in the first step.
Neuroleptic malignant syndrome: Possible relationship between neuroleptic treatment and smoking cessation: We discuss the implications of smoking cessation in the origin of the syndrome due to a lower metabolism of psychotropic medications, which previously had been well tolerated. We conclude that it is important to take into account the smoking and caffeine intake of these patients, as well as other metabolic inductor or inhibitor drugs.
Prediction of human errors by maladaptive changes in event-related brain networks — PNAS: Our findings provide insights into the brain network dynamics preceding human performance errors and suggest that monitoring of the identified precursor states may help in avoiding human errors in critical real-world situations.